Sanofi — insider trades

Stock trades Sanofi reported on SEC Form 4 at LTGO Latigo Biotherapeutics, Inc., ATTO Attovia Therapeutics, Inc..

• Aug 6, 2026: bought 300,000 shares of ATTO Attovia Therapeutics, Inc. ($5.10M)